Centiva Capital’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-3,800
Closed -$270K 1844
2023
Q3
$270K Buy
+3,800
New +$284K 0.01% 1229
2019
Q1
Sell
-15,600
Closed -$929K 322
2018
Q4
$929K Hold
15,600
0.07% 148
2018
Q3
$1.04M Buy
+15,600
New +$1.04M 0.09% 101

Other funds holding CL

Centiva Capital's CL Position: Q3 2025 in Review

Centiva Capital sold out of Colgate-Palmolive (CL) in Q3 2025, closing a stake of 7,365 shares — an estimated $669K sold.

Centiva Capital first reported a position in CL in Q3 2018 and held it in 15 quarters. The position peaked at $3.65M in Q2 2023. 1,843 funds tracked by Wall St. Rank hold CL as of Q3 2025.

  • Centiva Capital reported no remaining Colgate-Palmolive position as of Q3 2025 after selling out during the quarter.
  • Centiva Capital sold 7,365 Colgate-Palmolive shares in Q3 2025, an estimated $669K.
  • Centiva Capital first reported a position in Colgate-Palmolive in Q3 2018 and held it in 15 quarters.
  • Centiva Capital's Colgate-Palmolive position peaked at $3.65M in Q2 2023.
  • 1,843 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q3 2025.

Based on Centiva Capital's 13F filing for Q3 2025, filed 14 Nov 2025.